Indivior Pharmaceuticals Inc ( INDV) - Key Metrics
INDV Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $2.74 | $0.97 | $1.83 | $1.77 |
| 2026Q1 | $2.53 | $0.71 | -$0.07 | -$0.23 |
| 2025Q4 | $2.86 | $0.82 | -$1.77 | -$1.96 |
| 2025Q3 | $2.51 | $0.34 | -$0.31 | -$0.47 |
| 2025Q2 | $2.44 | $0.15 | $1.28 | $1.13 |
INDV Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 10.57 |
| 2026Q1 | 0% | 10.73 |
| 2025Q4 | 0% | 10.94 |
| 2025Q3 | 0% | 17.73 |
| 2025Q2 | 0% | 26.32 |
INDV Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 4.32% | 0% |
| 2026Q1 | -0.76% | 0% |
| 2025Q4 | -5.46% | 0% |
| 2025Q3 | -1.96% | 0% |
| 2025Q2 | 7.68% | 0% |
INDV
Price: $34.16
52 week price:
Earnings Per Share: 2.79 USD
P/E Ratio: 13.79
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 4.5 billion